Attached files
file | filename |
---|---|
10-Q - SignPath Pharma, Inc. | v203157_10q.htm |
EX-31.1 - SignPath Pharma, Inc. | v203157_ex31-1.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO SECTION 906
OF
THE SARBANES-OXLEY ACT OF 2002
In
connection with the quarterly report on Form 10-Q for the period ended September
30, 2010, as filed with the Securities and Exchange Commission on the date
hereof (the “Report”), I, Dr. Lawrence Helson, Chief Executive Officer and Chief
Financial Officer of SignPath Pharma Inc. (the “Company”), hereby certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:
(a)
|
The
Quarterly Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934;
and
|
(b)
|
The
information contained in the Quarterly Report fairly presents, in all
material respects, the financial condition and results of operations of
the Company.
|
Dated: November
17, 2010
|
SIGNPATH PHARMA INC. | |
By:
|
/s/ Lawrence Helson | |
Dr.
Lawrence Helson
|
||
Chief
Executive Officer and
|
||
Chief
Financial Officer
|
||
(Principal
Executive Officer and Principal
Financial
and Accounting
Officer)
|
A signed
original of this written statement required by Section 906, or other document
authenticating, acknowledging or otherwise adopting the signature that appears
in typed form within the electronic version of this written statement required
by Section 906, has been provided to SignPath Pharma Inc. and will be retained
by SignPath Pharma Inc. and furnished to the Securities and Exchange Commission
or its staff upon request.